Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today reports 2021 second quarter financial results and provides a status update on the Companys development portfolio.
In the second quarter, we saw an acceleration of growth of Jakafi® (ruxolitinib)…
